A study conducted by professor Yaakov Nahmias at Hebrew University in Israel has found that an existing cholesterol drug, fenofibrate, could ‘downgrade’ Covid-19 threat level to that of a common cold. The findings allegedly come from lab tests on human lung tissue infected with SARS-CoV-2, the virus that causes Covid-19 . . .